Detalles de la búsqueda
1.
Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation.
J Eur Acad Dermatol Venereol
; 37(9): 1731-1738, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37184282
2.
Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis: a post hoc pooled analysis of AMAGINE-2 and -3.
J Eur Acad Dermatol Venereol
; 36(8): 1275-1283, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279890
3.
Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of patients with psoriasis that are linked with skin improvement.
Br J Dermatol
; 185(3): 605-615, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657656
4.
Secukinumab 2-weekly vs. 4-weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN study.
Br J Dermatol
; 184(5): 849-856, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32652528
5.
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study.
Br J Dermatol
; 184(3): 425-436, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32479641
6.
Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study.
Br J Dermatol
; 185(6): 1160-1168, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33837519
7.
ActiPso: definition of activity types for psoriatic disease: A novel marker for an advanced disease classification.
J Eur Acad Dermatol Venereol
; 35(10): 2027-2033, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34076926
8.
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method.
J Eur Acad Dermatol Venereol
; 35(5): 1161-1175, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33480102
9.
A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE).
J Eur Acad Dermatol Venereol
; 35(3): 701-711, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32939860
10.
Quality of psoriasis care in Germany - results from the nationwide health care studies PsoHealth 2004-2017.
J Eur Acad Dermatol Venereol
; 35(7): 1536-1542, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33714231
11.
Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.
J Eur Acad Dermatol Venereol
; 35(12): 2409-2414, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255891
12.
Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results.
J Eur Acad Dermatol Venereol
; 35(2): 431-440, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32426889
13.
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations.
J Eur Acad Dermatol Venereol
; 35(2): 281-317, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33547728
14.
[Systemic treatment of moderate/severe hidradenitis suppurativa]. / Systemische Therapie der mittelschweren/schweren Hidradenitis suppurativa.
Hautarzt
; 72(8): 686-691, 2021 Aug.
Artículo
en Alemán
| MEDLINE | ID: mdl-34189590
15.
Joint Statement (DZK, DGRh, DDG) on the Tuberculosis Risk with Treatment Using Novel Non-TNF-Alpha Biologicals.
Pneumologie
; 75(4): 293-303, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33598901
16.
A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment.
Br J Dermatol
; 182(4): 869-879, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31376153
17.
Continued treatment with secukinumab is associated with high retention or regain of response.
Br J Dermatol
; 182(1): 67-75, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30972746
18.
Perception and determinants of stigmatization of people with psoriasis in the German population.
J Eur Acad Dermatol Venereol
; 34(12): 2846-2855, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32277524
19.
The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis.
J Eur Acad Dermatol Venereol
; 34(8): 1695-1706, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32022950
20.
Baseline characteristics of patients with moderate-to-severe psoriasis according to previous systemic treatment exposure: the PROSE study population.
J Eur Acad Dermatol Venereol
; 34(11): 2548-2556, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32239541